EMR SVP & CMO reports equity awards; 36,872 shares owned

Rhea-AI Filing Summary

Emerson Electric (EMR) reported an insider equity transaction by Senior VP & CMO Vidya Ramnath. On 11/03/2025, the officer acquired 10,387 shares upon payout of a performance share award under a shareholder‑approved plan pursuant to Rule 16b-3, reflecting achieved financial targets for the period ended September 30, 2025.

To cover required taxes at a fair market value of $139.46, 2,494 shares were withheld. The officer also received a grant of 3,234 restricted stock units pursuant to Rule 16b-3(d). Following these transactions, 36,872 shares were beneficially owned on a direct basis.

Insights

Equity compensation and insider transactions analyst

Routine equity awards and tax withholding; neutral impact.

Emerson Electric disclosed Form 4 activity for its SVP & CMO tied to a shareholder-approved plan. The officer received 10,387 shares from a performance share payout and a grant of 3,234 RSUs, both pursuant to Rule 16b-3. These are standard non-cash compensation events.

The filing also notes withholding of 2,494 shares at a fair market value of $139.46 to satisfy taxes, a common practice that does not involve open-market sales. Beneficial ownership after the transactions is 36,872 shares, held directly.

As administrative, plan-based awards, the items do not signal a change in strategy or outlook. Actual market impact depends on future vesting and holding decisions; the filing lists no timing beyond the 11/03/2025 transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramnath Vidya

(Last) (First) (Middle)

C/O EMERSON ELECTRIC CO.

8027 FORSYTH BLVD.

(Street)

ST. LOUIS MO 63105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EMERSON ELECTRIC CO [ EMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP &CMO

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		A(1)		10,387(1)	A	(2)	36,132	D
Common Stock	11/03/2025		F(3)		2,494(3)	D	$139.46(4)	33,638	D
Common Stock	11/03/2025		A(5)		3,234(5)	A	(6)	36,872	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquisition of shares pursuant to Rile 16b-3 upon payout of 10,387 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2025.

2. Price is not applicable to the acquisition described in Note 1.

3. Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1.

4. Fair market value on date of withholding described in Note 1.

5. Grant to Reporting Person of 3,234 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d).

6. Price is not applicable to acquisitions resulting from grants of restricted stock units.

Remarks:

	/s/ John Sperino, Attorney-in-Fact for Vidya Ramnath	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EMR’s SVP & CMO report on Form 4?

An acquisition of 10,387 shares from a performance share payout, tax withholding of 2,494 shares, and a grant of 3,234 RSUs.

What is the fair market value used for EMR’s tax withholding?

The filing lists a fair market value of $139.46 per share for the withholding.

How many EMR shares does the officer own after the transactions?

Beneficial ownership following the reported transactions is 36,872 shares, held directly.

When did the EMR insider transactions occur?

The transactions occurred on 11/03/2025.

Were these EMR transactions open-market buys or sales?

No. Shares were acquired via plan awards and 2,494 shares were withheld to cover taxes; no open-market trades are listed.

Under what rule were the EMR awards reported?

The performance payout and RSU grant were reported pursuant to Rule 16b-3 under a shareholder-approved plan.